Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation
Heba A Abou-Taleb,1 Rasha A Khallaf,2 Jelan A Abdel-Aleem3 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Nahda University (NUB), Beni Suef, Egypt; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt; 3Departm...
Main Authors: | Abou-Taleb HA, Khallaf RA, Abdel-Aleem JA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/intranasal-niosomes-of-nefopam-with-improved-bioavailability-preparati-peer-reviewed-article-DDDT |
Similar Items
-
Nefopam hydrochloride as a component of multimodal analgesia in the postoperative period
by: Andrii Semenenko
Published: (2020-06-01) -
Formulation Variables Effect on Gelation Temperature of Nefopam Hydrochloride intranasal in Situ Gel (Conference Paper) #
by: Ammar Alabdly, et al.
Published: (2023-02-01) -
Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation
by: Usama A. Fahmy, et al.
Published: (2020-05-01) -
Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box–Behnken design
by: S. Sukhbir, et al.
Published: (2016-09-01) -
Effect of Nefopam-Based Patient-Controlled Analgesia with and without Fentanyl on Postoperative Pain Intensity in Patients Following Laparoscopic Cholecystectomy: A Prospective, Randomized, Controlled, Double-Blind Non-Inferiority Trial
by: Ki Tae Jung, et al.
Published: (2021-03-01)